These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 27419812)

  • 21. "Since both of us are using antiretrovirals, we have been supportive to each other": facilitators and barriers of pre-exposure prophylaxis use in heterosexual HIV serodiscordant couples in Kisumu, Kenya.
    Patel RC; Stanford-Moore G; Odoyo J; Pyra M; Wakhungu I; Anand K; Bukusi EA; Baeten JM; Brown JM
    J Int AIDS Soc; 2016; 19(1):21134. PubMed ID: 27964776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence.
    Haberer JE; Kidoguchi L; Heffron R; Mugo N; Bukusi E; Katabira E; Asiimwe S; Thomas KK; Celum C; Baeten JM
    J Int AIDS Soc; 2017 Jul; 20(1):21842. PubMed ID: 28741331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gendered differences in the perceived risks and benefits of oral PrEP among HIV-serodiscordant couples in Kenya.
    Carroll JJ; Ngure K; Heffron R; Curran K; Mugo NR; Baeten JM
    AIDS Care; 2016 Aug; 28(8):1000-6. PubMed ID: 26754017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sexual Behavior and Perceived HIV Risk Among HIV-Negative Members of Serodiscordant Couples in East Africa.
    Wanga V; Baeten JM; Bukusi EA; Mugo NR; Asiimwe S; Ngure K; Mujugira A; Muwonge T; Odoyo JB; Haberer JE; Celum C; Heffron R;
    AIDS Behav; 2020 Jul; 24(7):2082-2090. PubMed ID: 31925607
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.
    Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Chaipung B; Worrajittanon D; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Holtz TH; Samandari T; Choopanya K;
    Lancet HIV; 2017 Feb; 4(2):e59-e66. PubMed ID: 27866873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Facilitators of adherence to the study pill in the FEM-PrEP clinical trial.
    Corneli A; Perry B; Agot K; Ahmed K; Malamatsho F; Van Damme L
    PLoS One; 2015; 10(4):e0125458. PubMed ID: 25867624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tenofovir-based preexposure prophylaxis for HIV infection among African women.
    Marrazzo JM; Ramjee G; Richardson BA; Gomez K; Mgodi N; Nair G; Palanee T; Nakabiito C; van der Straten A; Noguchi L; Hendrix CW; Dai JY; Ganesh S; Mkhize B; Taljaard M; Parikh UM; Piper J; Mâsse B; Grossman C; Rooney J; Schwartz JL; Watts H; Marzinke MA; Hillier SL; McGowan IM; Chirenje ZM;
    N Engl J Med; 2015 Feb; 372(6):509-18. PubMed ID: 25651245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP.
    Corneli A; Wang M; Agot K; Ahmed K; Lombaard J; Van Damme L;
    J Acquir Immune Defic Syndr; 2014 Dec; 67(5):555-63. PubMed ID: 25393942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention.
    Donnell D; Baeten JM; Bumpus NN; Brantley J; Bangsberg DR; Haberer JE; Mujugira A; Mugo N; Ndase P; Hendrix C; Celum C
    J Acquir Immune Defic Syndr; 2014 Jul; 66(3):340-8. PubMed ID: 24784763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Women's experiences with oral and vaginal pre-exposure prophylaxis: the VOICE-C qualitative study in Johannesburg, South Africa.
    van der Straten A; Stadler J; Montgomery E; Hartmann M; Magazi B; Mathebula F; Schwartz K; Laborde N; Soto-Torres L
    PLoS One; 2014; 9(2):e89118. PubMed ID: 24586534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial.
    Choopanya K; Martin M; Suntharasamai P; Sangkum U; Mock PA; Leethochawalit M; Chiamwongpaet S; Kitisin P; Natrujirote P; Kittimunkong S; Chuachoowong R; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Hendrix CW; Vanichseni S;
    Lancet; 2013 Jun; 381(9883):2083-90. PubMed ID: 23769234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preexposure prophylaxis for HIV prevention: where have we been and where are we going?
    Baeten JM; Haberer JE; Liu AY; Sista N
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S122-9. PubMed ID: 23764623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An empiric risk scoring tool for identifying high-risk heterosexual HIV-1-serodiscordant couples for targeted HIV-1 prevention.
    Kahle EM; Hughes JP; Lingappa JR; John-Stewart G; Celum C; Nakku-Joloba E; Njuguna S; Mugo N; Bukusi E; Manongi R; Baeten JM;
    J Acquir Immune Defic Syndr; 2013 Mar; 62(3):339-47. PubMed ID: 23187945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preexposure prophylaxis for HIV infection among African women.
    Van Damme L; Corneli A; Ahmed K; Agot K; Lombaard J; Kapiga S; Malahleha M; Owino F; Manongi R; Onyango J; Temu L; Monedi MC; Mak'Oketch P; Makanda M; Reblin I; Makatu SE; Saylor L; Kiernan H; Kirkendale S; Wong C; Grant R; Kashuba A; Nanda K; Mandala J; Fransen K; Deese J; Crucitti T; Mastro TD; Taylor D;
    N Engl J Med; 2012 Aug; 367(5):411-22. PubMed ID: 22784040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana.
    Thigpen MC; Kebaabetswe PM; Paxton LA; Smith DK; Rose CE; Segolodi TM; Henderson FL; Pathak SR; Soud FA; Chillag KL; Mutanhaurwa R; Chirwa LI; Kasonde M; Abebe D; Buliva E; Gvetadze RJ; Johnson S; Sukalac T; Thomas VT; Hart C; Johnson JA; Malotte CK; Hendrix CW; Brooks JT;
    N Engl J Med; 2012 Aug; 367(5):423-34. PubMed ID: 22784038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women.
    Baeten JM; Donnell D; Ndase P; Mugo NR; Campbell JD; Wangisi J; Tappero JW; Bukusi EA; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kakia A; Odoyo J; Mucunguzi A; Nakku-Joloba E; Twesigye R; Ngure K; Apaka C; Tamooh H; Gabona F; Mujugira A; Panteleeff D; Thomas KK; Kidoguchi L; Krows M; Revall J; Morrison S; Haugen H; Emmanuel-Ogier M; Ondrejcek L; Coombs RW; Frenkel L; Hendrix C; Bumpus NN; Bangsberg D; Haberer JE; Stevens WS; Lingappa JR; Celum C;
    N Engl J Med; 2012 Aug; 367(5):399-410. PubMed ID: 22784037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unraveling the divergent results of pre-exposure prophylaxis trials for HIV prevention.
    van der Straten A; Van Damme L; Haberer JE; Bangsberg DR
    AIDS; 2012 Apr; 26(7):F13-9. PubMed ID: 22333749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.
    Ware NC; Wyatt MA; Haberer JE; Baeten JM; Kintu A; Psaros C; Safren S; Tumwesigye E; Celum CL; Bangsberg DR
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):463-8. PubMed ID: 22267018
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study.
    Eisingerich AB; Wheelock A; Gomez GB; Garnett GP; Dybul MR; Piot PK
    PLoS One; 2012; 7(1):e28238. PubMed ID: 22247757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.
    Grant RM; Lama JR; Anderson PL; McMahan V; Liu AY; Vargas L; Goicochea P; Casapía M; Guanira-Carranza JV; Ramirez-Cardich ME; Montoya-Herrera O; Fernández T; Veloso VG; Buchbinder SP; Chariyalertsak S; Schechter M; Bekker LG; Mayer KH; Kallás EG; Amico KR; Mulligan K; Bushman LR; Hance RJ; Ganoza C; Defechereux P; Postle B; Wang F; McConnell JJ; Zheng JH; Lee J; Rooney JF; Jaffe HS; Martinez AI; Burns DN; Glidden DV;
    N Engl J Med; 2010 Dec; 363(27):2587-99. PubMed ID: 21091279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.